✦ LIBER ✦

Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: A national cohort study

✍ Scribed by Saadatmand, Sepideh; Vos, Janet R.; Hooning, Maartje J.; Oosterwijk, Jan C.; Koppert, Linetta B.; de Bock, Geertruida H.; Ausems, Margreet G.; van Asperen, Christi J.; Aalfs, Cora M.; Gómez Garcia, Encarna B.; Meijers-Heijboer, Hanne; Hoogerbrugge, Nicoline; Piek, Marianne; Seynaeve, Caroline; Verhoef, Cornelis; Rookus, Matti; Tilanus-Linthorst, Madeleine M.

Book ID: 121789038
Publisher: John Wiley and Sons
Year: 2014
Tongue: French
Weight: 615 KB
Volume: 135
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.28941

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Screening mammography and risk of breast

Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study

✍ Steven A Narod; Jan Lubinski; Parviz Ghadirian; Henry T Lynch; Pal Moller; Willi 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 90 KB

The efficacy of taxane chemotherapy for

The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers

✍ Mieke Kriege; Agnes Jager; Maartje J. Hooning; Elisabeth Huijskens; Jannet Blom; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 824 KB

Risk-reducing surgery, screening and che

Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study

✍ K-A Phillips; MA Jenkins; GJ Lindeman; SA McLachlan; JM McKinley; PC Weideman; J 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Tamoxifen and risk of contralateral brea

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study

✍ Steven A Narod; Jean-Sébastien Brunet; Parviz Ghadirian; Mark Robson; Ketil Heim 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 98 KB

119 Efficacy of Bilateral Risk-reducing

119 Efficacy of Bilateral Risk-reducing Mastectomy on Primary Breast Cancer Risk in Healthy BRCA1 and BRCA2 Mutation Carriers

✍ A. Heemskerk-Gerritsen; M. Hooning; M.M.A. Tilanus-Linthorst; A. Jager; C.H.M. v 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Targeted Prostate Cancer Screening in BR

Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

✍ Bancroft, Elizabeth K.; Page, Elizabeth C.; Castro, Elena; Lilja, Hans; Vickers, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 443 KB